Efficacy of Immunotherapy in Second-Line Treatment of <i>KRAS</i>-Mutated Patients with Non-Small-Cell Lung Cancer-Data from Daily Practice.

Knetki-Wróblewska, Magdalena; Tabor, Sylwia; Pluzanski, Adam; Lewandowska, Zofia; Tysarowski, Andrzej; Pawlik, Hubert; Kowalski, Dariusz M; Krzakowski, Maciej

Efficacy of Immunotherapy in Second-Line Treatment of KRAS-Mutated Patients with Non-Small-Cell Lung Cancer-Data from Daily Practice.

Knetki-Wróblewska, Magdalena; Tabor, Sylwia; Pluzanski, Adam; Lewandowska, Zofia; Tysarowski, Andrzej; Pawlik, Hubert; Kowalski, Dariusz M; Krzakowski, Maciej.

Afiliação

Knetki-Wróblewska M; Department of Lung Cancer and Thoracic Tumours, The Maria Sklodowska-Curie National Research Institute of Oncology, 02-781 Warsaw, Poland.
Tabor S; Department of Lung Cancer and Thoracic Tumours, The Maria Sklodowska-Curie National Research Institute of Oncology, 02-781 Warsaw, Poland.
Pluzanski A; Department of Lung Cancer and Thoracic Tumours, The Maria Sklodowska-Curie National Research Institute of Oncology, 02-781 Warsaw, Poland.
Lewandowska Z; Department of Lung Cancer and Thoracic Tumours, The Maria Sklodowska-Curie National Research Institute of Oncology, 02-781 Warsaw, Poland.
Tysarowski A; Cancer Molecular and Genetic Diagnostics Department, The Maria Sklodowska-Curie National Research Institute of Oncology, 02-781 Warsaw, Poland.
Pawlik H; Computational Oncology Department, The Maria Sklodowska-Curie National Research Institute of Oncology, 02-781 Warsaw, Poland.
Kowalski DM; Department of Lung Cancer and Thoracic Tumours, The Maria Sklodowska-Curie National Research Institute of Oncology, 02-781 Warsaw, Poland.
Krzakowski M; Department of Lung Cancer and Thoracic Tumours, The Maria Sklodowska-Curie National Research Institute of Oncology, 02-781 Warsaw, Poland.

Curr Oncol ; 30(1): 462-475, 2022 12 29.

Article em En | MEDLINE | ID: mdl-36661686

Assuntos

Carcinoma Pulmonar de Células não Pequenas; Neoplasias Pulmonares; Humanos; Carcinoma Pulmonar de Células não Pequenas/tratamento farmacológico; Carcinoma Pulmonar de Células não Pequenas/genética; Neoplasias Pulmonares/tratamento farmacológico; Neoplasias Pulmonares/genética; Proteínas Proto-Oncogênicas p21(ras)/genética; Proteínas Proto-Oncogênicas p21(ras)/uso terapêutico; Estudos Retrospectivos; Imunoterapia

Palavras-chave

KRAS gene; NSCLC; atezolizumab; immunotherapy; nivolumab

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma Pulmonar de Células não Pequenas / Neoplasias Pulmonares Tipo de estudo: Observational_studies / Prognostic_studies Limite: Humans Idioma: En Revista: Curr Oncol Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google